Utility of an improved model of amyloid-beta (A beta(1-42)) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease
Journal Article
Overview
publication date
has subject area
Amyloidogenic Proteins - Amyloid beta-Peptides
Animal Diseases - Disease Models, Animal
Animal Population Groups - Animals, Genetically Modified
Animals
Brain Diseases - Alzheimer Disease
Caenorhabditis elegans
Central Nervous System Agents - Neuroprotective Agents
Clioquinol
Humans
Investigative Techniques - Drug Evaluation, Preclinical
Investigative Techniques - Drug Evaluation, Preclinical
Membrane Proteins - Amyloid beta-Peptides
Models, Animal - Disease Models, Animal
Models, Biological - Disease Models, Animal
Neurocognitive Disorders - Alzheimer Disease
Organisms, Genetically Modified - Animals, Genetically Modified
Peptides - Amyloid beta-Peptides
Physiological Effects of Drugs - Neuroprotective Agents
Tauopathies - Alzheimer Disease
has restriction
Date in CU Experts
September 3, 2013 2:53 AM
Full Author List
McColl G; Roberts BR; Pukala TL; Kenche VB; Roberts CM; Link CD; Ryan TM; Masters CL; Barnham KJ; Bush AI
author count
citation count
published in
Other Profiles
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
volume
number
